After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Orchestra BioMed Holdings Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Orchestra BioMed Holdings Inc is $110.72M. A total of 87475.0 shares were traded on the day, compared to an average of 495.02K shares.
In the most recent transaction, Fain Eric S sold 2,683 shares of OBIO for 3.05 per share on Jun 26 ’25. After the transaction, the Director now owns 50,949 company shares. In a previous transaction on Jun 26 ’25, Fain Eric S bought 2,683 shares at 3.05 per share.
Among the insiders who bought shares, RTW INVESTMENTS, LP acquired of 49,900 shares on Apr 30 ’25 at a per-share price of $2.99. This resulted in the 10% Owner holding 8,306,063 shares of OBIO after the transaction. In another insider transaction, RTW INVESTMENTS, LP bought 50,000 shares at $2.53 per share on Apr 29 ’25. Company shares held by the 10% Owner now total 8,256,163.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, OBIO has a high of $8.87 and a low of $2.37.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. OBIO’s latest balance sheet shows that the firm has $10.90M in Cash & Short Term Investments as of fiscal 2021. There were $5.67M in debt and $12.24M in liabilities at the time. Its Book Value Per Share was $0.44, while its Total Shareholder’s Equity was -$71.23M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OBIO is Buy with a score of 5.00.
